| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-005 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 第六届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届董事会第十九次 会议于2025年3月21日在公司会议室以现场结合通讯方式召开。本次董事会会议通 知已于2025年3月10日以电子邮件方式发出。本次董事会以现场方式参会董事4人， 以通讯方式参会董事5人，实际参与表决董事9人，公司监事和高级管理人员列席 会议。会议由公司董事长覃九三先生召集并主持。本次会议的召集、召开符合有 关法律、法规和《公司章程》的规定。 经表决形成如下决议： 一、审议通过了《关于<公司 2024 年年度报告及其摘要>的议案》 《公司 2024 年年度报告及其摘要》具体内容详见同日刊登在中国证监会指 定的创业板信息披露网站巨潮资讯网，《2024 年年度报告披露提示性公告》将 同时刊登于《证券时报》《上 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-010 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于公司2024年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、公司2024年度利润分配方案预案为：以实施权益分派股权登记日登记的 总股本扣除公司回购专户上已回购股份后的股本为基数，向全体股东每10股派发 现金红利人民币4元（含税），不送红股，不以资本公积金转增股本。 2、公司现金分红方案不涉及《深圳证券交易所创业板股票上市规则》第9.4 条相关规定的可能被实施其他风险警示情形。 一、审议程序 深圳新宙邦科技股份有限公司（以下简称"公司"）于2025年3月21日召开 第六届董事会第十九次会议、第六届监事会第十八次会议，审议通过了《关于公 司2024年度利润分配预案的议案》，该议案尚需提交公司2024年年度股东大会审 议。 1、董事会审议情况 2025年3月21日，公司召开第六届董事会第十九次会议，审议通过了《关 ...

Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in the latest fiscal year[13]. - The company's operating revenue for 2024 was ¥7,846,787,001.83, an increase of 4.85% compared to ¥7,483,950,240.16 in 2023[18]. - The net profit attributable to shareholders for 2024 was ¥942,053,300.08, a decrease of 6.83% from ¥1,011,067,526.26 in 2023[18]. - The net cash flow from operating activities for 2024 was ¥818,412,856.79, down 76.26% from ¥3,447,910,303.67 in 2023[18]. - The basic earnings per share for 2024 was ¥1.26, a decline of 7.35% compared to ¥1.36 in 2023[18]. - The total assets at the end of 2024 were ¥17,623,193,205.55, a slight decrease of 0.01% from ¥17,624,313,101.06 at the end of 2023[18]. - The net assets attributable to shareholders increased by 6.29% to ¥9,751,174,225.94 at the end of 2024, compared to ¥9,174,386,602.77 at the end of 2023[18]. - The company achieved operating revenue of CNY 7,846.79 million, a year-on-year increase of 4.85%[95]. - Net profit attributable to shareholders was CNY 942.05 million, a decrease of 6.83% year-on-year[88]. - Revenue from battery chemicals was CNY 5,115.62 million, representing 65.19% of total revenue, with a growth of 1.24%[95]. - Revenue from organic fluorine chemicals reached CNY 1,528.77 million, a year-on-year increase of 7.25%[90]. - Revenue from capacitor chemicals increased by 21.91% to CNY 766.35 million, driven by demand in emerging industries[91]. - Semiconductor chemicals revenue grew by 18.35% to CNY 36.78 million, with significant growth in integrated circuit applications[92]. Market Expansion and Strategy - The company is focusing on expanding its market presence, particularly in the Asia-Pacific region, aiming for a 20% increase in market share by 2025[13]. - The company is expanding its market presence with projects in Nantong, Chongqing, and the United States, focusing on battery chemicals and semiconductor materials[71]. - The company plans to expand its market presence and is focusing on new product development in the electronic materials sector, particularly in lithium battery materials[186]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings[186]. - A strategic acquisition of a local competitor is in progress, which is anticipated to increase market penetration by 15%[197]. - The company aims to enhance its competitive advantage through strategic layout and innovation mechanisms in 2025[157]. - The company will implement a "go global" strategy to establish production bases overseas for localized resource supply[158]. Research and Development - The company has allocated 10 million RMB for research and development in new technologies for electronic chemicals in the upcoming year[13]. - The company has increased its R&D investment to enhance its technological and product capabilities, expanding its product categories to provide competitive solutions for clients[44]. - The company has developed new products in various fields, including sodium-ion battery electrolytes and high-voltage system electrolytes, focusing on high energy density and safety[78]. - The company aims to enhance its R&D capabilities, targeting a 20% increase in R&D investment for the upcoming fiscal year[186]. - The company has established 30 innovation platforms, including a lithium-ion battery electrolyte engineering laboratory, to enhance its research and development capabilities[78]. - The company has applied for over 10 patents related to lithium-ion battery electrolytes and additives, demonstrating advanced and reliable technology that significantly improves battery performance in high-temperature storage and cycling[69]. - The company has a strong focus on R&D in fluorinated fine chemicals, with stable growth in high-end fluorinated materials and a solid customer base[64]. Product Development and Innovation - New product development includes advanced materials for lithium-ion batteries, projected to enhance performance by 30% compared to previous models[13]. - The company has successfully achieved small-scale shipments of solid-state electrolytes and has begun mass delivery of sodium-ion battery electrolytes, indicating advancements in product innovation[32]. - The company has developed high-performance electrolyte solutions for lithium-ion batteries, achieving fast charging capabilities and extended cycle life[99]. - The company has developed high-energy density lithium iron phosphate electrolytes for passenger vehicles, enhancing competitiveness in the market[113]. - The company has developed a new insulation gas product to replace sulfur hexafluoride (SF6), which is expected to significantly reduce carbon emissions in the power grid equipment lifecycle[114]. - The company has developed a new ECOSIP TM Technology for producing carbonate solvents from ethylene oxide, which is characterized by high purity, low energy consumption, and flexible supply of five types of products[69]. Supply Chain and Operational Efficiency - The company is implementing new strategies to improve supply chain efficiency, targeting a reduction in operational costs by 15%[13]. - The company has established strategic partnerships with major clients, leveraging its technological, cost, and delivery advantages to enhance product development and market opportunities[42]. - The company has established a strategic procurement framework with suppliers to enhance cost competitiveness and ensure stable supply of raw materials[159]. - The company is enhancing its supply chain resilience to mitigate risks associated with raw material price fluctuations and supply security[159]. Environmental and Safety Initiatives - The company is committed to safety and environmental protection, adhering to strict regulations and investing in EHS management systems[161]. - The company emphasizes sustainable development by integrating green practices throughout the product lifecycle, aiming to reduce pollution and promote green chemistry[162]. - The company is actively tracking regulatory changes regarding PFAS substances and is developing eco-friendly products to meet compliance requirements[164]. - The company is committed to continuous improvement in production processes to align with safety and environmental standards[161]. Governance and Investor Relations - The company has established a robust internal control system to enhance governance and operational compliance[171]. - The company emphasizes shareholder return and aims to enhance investor satisfaction through effective governance and communication[168]. - The company has implemented a performance evaluation and incentive mechanism for senior management, aligning with its current development needs[176]. - The company received the highest rating of "A" in the Shenzhen Stock Exchange's 2023 information disclosure assessment, continuing its streak of "A" ratings from 2021 and 2022[178]. - The company has a structured approach to determine remuneration based on performance, responsibilities, capabilities, and market salary levels[199]. Future Outlook - The company anticipates a rapid growth opportunity in battery chemicals over the next 5-10 years due to the global push for clean energy[154]. - Future guidance suggests a revenue growth target of 30% for the next fiscal year, supported by new product launches and market expansion strategies[186]. - The company is committed to enhancing its research and development capabilities in new technologies related to fluorinated materials[130].

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-003 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 关于回购股份进展情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司 深圳新宙邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召 开第六届董事会第十一次会议、第六届监事会第十一次会议，于 2024 年 5 月 14 日召开 2024 年第一次临时股东大会，审议通过了《关于回购公司股份方案的议 案》，同意公司使用自有资金以集中竞价交易方式回购公司已发行的部分人民币 普通股（A 股）股份（以下简称"本次回购"），本次回购股份将予以注销并相应 减少公司注册资本。本次回购资金总额不低于人民币 10,000 万元（含本数）且不 超过人民币 20,000 万元（含本数），具体回购资金金额以回购实施完成时实际回 购的金额为准。本次回购价格不超过人民币 45 元/股（含本数）。具体内容详见 公司于 2024 年 4 月 26 日在巨潮资 ...

证券简称：新宙邦 证券代码：300037 深圳新宙邦科技股份有限公司 投资者关系活动记录表 编号：2025-001 | 投资者关系活 □ | 特定对象调研 分析师会议 媒体采访 □ □ | | | | --- | --- | --- | --- | | 动类别 □ | 业绩说明会 新闻发布会 路演活动 □ □ | | | | □ | 现场参观 ☑ 电话会议 | | 其他 | | 参与单位名称 | 参会单位名称详见后文附表 | | | | 及人员姓名 | | | | | 时间 | 年 01 月 21 日 16:00-17:00 | 2025 | | | 地点 | 电话会议 | | | | 上市公司接待 | 董事长：覃九三 | | | | 人员姓名 | 董事会秘书：贺靖策 | | | | | 近期公司市场波动比较大，公司关注度大幅提升，成交量也明显放大， | | | | | 为助力广大投资者更好地理解公司价值与发展潜力，建立对公司未来长期 | | | | | 发展的信心，特别举办本次近况交流会。 | | | | | 在本次交流活动中，公司严格遵守信息披露相关规定，保证信息披露 | | | | | 真实、准确、及时 ...

目前对公司业绩影响非常小。 证券时报e公司讯，新宙邦1月20日在互动平台表示，公司对于固态电池领域下游厂商的发展一直保持密 切关注并积极进行相关产品的配套研发与生产。 公司一直以来保持高的技术研发投入，目前有氧化物体系、硫化物体系和聚合物体系的固态电解质成熟 产品，并已与下游客户合作实现了产业化应用，其中氧化物电解质已实现量产销售，也在按客户的未来 需求对产能进行积极布局。 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-001 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于 2024 年第四季度可转换公司债券转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、"宙邦转债"（债券代码：123158）转股期限为 2023 年 3 月 30 日至 2028 年 9 月 25 日；最新的转股价格为人民币 41.38 元/股。 2、2024 年第四季度，共有 410 张"宙邦转债"完成转股（票面金额共计人 民币 41,000 元），合计转成 990 股"新宙邦"股票（证券代码：300037）。 3、截至2024年第四季度末，公司剩余可转换公司债券张数为19,694,036张， 剩余可转换公司债券票面总额为人民币 1,969,403,600 元。 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 15 号——可转换公司债券》的有关规定，深圳新宙邦科技股份有 限公司（以 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-002 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召 开第六届董事会第十一次会议、第六届监事会第十一次会议，于 2024 年 5 月 14 日召开 2024 年第一次临时股东大会，审议通过了《关于回购公司股份方案的议 案》，同意公司使用自有资金以集中竞价交易方式回购公司已发行的部分人民币 普通股（A 股）股份（以下简称"本次回购"），本次回购股份将予以注销并相应 减少公司注册资本。本次回购资金总额不低于人民币 10,000 万元（含本数）且不 超过人民币 20,000 万元（含本数），具体回购资金金额以回购实施完成时实际回 购的金额为准。本次回购价格不超过人民币 45 元/股（含本数）。具体内容详见 公司于 2024 年 4 月 26 日在巨潮资讯网上披露的《关于回购公司股份方案的公 告》（公告编号： ...

中信证券股份有限公司 关于深圳新宙邦科技股份有限公司 （二）交易金额 公司及子公司拟开展商品套期保值业务的保证金及权利金上限（包括为 交易而提供的担保物价值、预计占用的金融机构授信额度、为应急措施所预留 的保证金等）不超过人民币 8,000 万元，且任一交易日持有的最高合约价值不 超过人民币 4 亿元，该额度在审批期限内可循环滚动使用。 （三）交易方式 公司及子公司开展的期货套期保值业务仅限于在境内商品期货交易所挂 1 开展商品期货套期保值业务的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为深 圳新宙邦科技股份有限公司（以下简称"新宙邦"或"公司"）向不特定对象发 行可转换公司债券的保荐机构，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引 第2号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引 第13号——保荐业务》等相关法律、法规和规范性文件的规定，对新宙邦开展 商品期货套期保值业务的事项进行了核查，发表如下意见： 一、开展商品期货套期保值业务的概述 （一）交易目的 鉴于公司主要原材料碳酸锂的价格受市场 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-095 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于控股子公司投资建设 三明海斯福氟新材料研究中心建设项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"或"新宙邦"）于 2024 年 12 月 26 日召开第六届董事会第十八次会议、第六届监事会第十七次会议，审 议通过了《关于控股子公司投资建设三明海斯福氟新材料研究中心建设项目的议 案》。现就相关事宜公告如下： 一、投资概况 1、深圳新宙邦科技股份有限公司拟以控股子公司三明市海斯福化工有限责 任公司（以下简称"海斯福"）为项目实施主体，在福建省三明市明溪县城关乡 上坊村南山投资建设三明海斯福氟新材料研究中心建设项目，项目计划总投资不 超过 1.5 亿元，建设周期 20 个月（项目总投资额和建设周期以实际投资建设情 况为准）。 2、本次投资建设的资金来源为海斯福自有资金或自筹资金，后续如需改变 资 ...